(Q34940824)

5 August 2017

1 reference

title

Statins and renal function (English)

1 reference

5 August 2017

author

Dimitri P Mikhailidis

series ordinal

2

object named as

Dimitri P Mikhailidis

1 reference

5 August 2017

Moses Elisaf

1

1 reference

5 August 2017

publication date

1 September 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

53

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

493-502

1 reference

Focal and segmental glomerulosclerosis: analogies to atherosclerosis

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Is there a role for polyunsaturated fatty acids in the prevention of renal disease and renal failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. Hypertension Care Computing Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Simvastatin inhibits PDGF-induced DNA synthesis in human glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Partial remission of nephrotic syndrome in patient on long-term simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Effect of atorvastatin on serum uric acid levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Effect of fluvastatin on endothelium-dependent brachial artery vasodilation in patients after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Impaired renal vascular endothelial function in vitro in experimental hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

High-dose simvastin (80 mg/day) decreases plasma concentrations of total homocyst(e)ine in patients with hypercholesteromia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Effects of fenofibrate and gemfibrozil on plasma homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Effects of fenofibrate and gemfibrozil on plasma homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Renal function, plasma homocysteine and carotid atherosclerosis in elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Clinical characteristics of ischaemic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Incidental renal artery stenosis in peripheral vascular disease: a case for treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Hyperlipidemia in solid organ transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Effect of pravastatin on outcomes after cardiac transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Lipoprotein (a) and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Platelets and lipoprotein (a): a brief overview of their role in the pathogenesis of atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Dose-response effects of atorvastatin and simvastatin on high-density lipoprotein cholesterol in hypercholesterolaemic patients: a review of five comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Drug treatment of combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Smoking diminishes the beneficial effect of statins: observations from the landmark trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

A pharmacoepidemiological assessment of the effect of statins and fibrates on fibrinogen concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Effect of ciprofibrate on C-reactive protein and fibrinogen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Platelet function and lipid-lowering interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Pleiotropic effects of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Doxazosin, an alpha1-adrenoceptor antagonist, inhibits serotonin-induced shape change in human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Angiotensin II can induce and potentiate shape change in human platelets: effect of losartan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Statins and blood pressure regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Treating dyslipidaemia in non-insulin-dependent diabetes mellitus -- a special reference to statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Angiographic progression of coronary artery disease in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Efficacy and drug interactions of the new HMG-CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Clinical pharmacokinetics of fluvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Hemostatic problems and thromboembolic complications in nephrotic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970205300501

10.1177/000331970205300501

21 January 2018

Identifiers

DOI

0 references

1 reference